Rev. Bras. Cardiol. Invasiva vol.20 número2

This study is a subanalysis of a prospective, randomised trial comparing the eficacy of the provisional technique versus two-stent implantation in 59 patients with a single

After the test phase of this new drug-eluting balloon is inished, including clinical trials, a drug known to drug-eluting stents, sirolimus, may become a new option for

2–7 In recent years, several percutaneous techniques have been developed for the treatment of bifurcation lesions; however, the risk of side branch impairment (failure)

The implanted stents that were dilated with a sirolimus- eluting balloon with an excipient:sirolimus formulation of 1:1 presented lower neointimal area, lower neointimal

indicate that the atheromatous plaques treated by bare- metal stenting and that develop signiicant neointimal hyperplasia exhibit an increased expression of genes related to

The present study aimed to report the nine-month angiographic follow-up and the long-term clinical outcomes of patients treated with the Amazonia PAX ® stent in a

Conclusions: PCI in patients with acute coronary syndromes receiving fondaparinux was associated with a low rate of major adverse cardiovascular ischaemic events and severe

6 In a recent study, the analysis of a population of young patients with premature coronary disease after percutaneous intervention showed a mortality between 6% and 7% at